Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.

Trial Profile

Effects of Simvastatin and Rosiglitazone Combination in Patients With the Metabolic Syndrome.

Completed
Phase of Trial: Phase II/III

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Rosiglitazone (Primary) ; Simvastatin (Primary)
  • Indications Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms SIROCO
  • Most Recent Events

    • 27 Feb 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
    • 27 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Feb 2012 Results published in Diabetes, Obesity and Metabolism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top